Inflammatory cytokine receptor (None universally adopted; may use abbreviations for specific members (e.g., TNFR for Tumor necrosis factor receptor, IL-6R for Interleukin-6 receptor))

Inflammatory cytokine receptors are a diverse family of cell-surface molecules that recognize and bind pro-inflammatory cytokines such as TNF-α, IL-1, IL-6, IL-17, IL-23, and various interferons. These receptors are essential for activating and regulating immune responses; their engagement triggers intracellular signaling cascades commonly involving the JAK/STAT pathway or other kinase networks, leading to gene expression changes that mediate inflammation, cell proliferation, differentiation, and survival. Dysregulation of inflammatory cytokine receptor signaling is central to the pathogenesis of autoimmune diseases (e.g., rheumatoid arthritis, psoriasis), cancer, and infectious diseases. Targeted therapies that block cytokine-receptor interactions have transformed the management of these conditions but present safety challenges related to immune suppression and systemic inflammatory risks. This term encompasses a wide range of specific receptors (e.g., TNF receptor, IL-6 receptor), which are best analyzed individually for therapeutic targeting and structured drug information.

Other names

Cytokine receptorsimmune cytokine receptorspro-inflammatory cytokine receptorsspecific names like TNF receptorIL-6 receptorIL-1 receptoretc.

Receptor antagonism or blockade to inhibit cytokine signaling (e.g., neutralizing antibodies) Ligand/receptor decoys (e.g., soluble receptor constructs) Modulation of downstream signal transduction (e.g., JAK inhibitors for receptors that activate JAK kinases) Agonistic or immunostimulatory actions (e.g., engineered IL-2 or IL-12 for cancer immunotherapy)